PROTEOMEDIX
ProteoMediX is a spinoff company of ETH Zurich and specialized in the identification of novel biomarkers for the early detection of cancer and the personalized treatment thereof.The first product currently developed is a blood-based test that enables the diagnosis of prostate cancer with significantly higher accuracy than today's clinical standard.This reduces unnecessary biopsies and thus results in significant cost savings for the healthcare system and less discomfort for the patient.
PROTEOMEDIX
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2010-03-01
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.proteomedix.com
Total Employee:
1+
Status:
Active
Contact:
41 44 733 40 90
Total Funding:
21.35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Google Tag Manager Google Universal Analytics Global Site Tag Mobile Non Scaleable Content Nginx Google Maps
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Fagron SA
Fagron is a pharmaceutical company specializing in chemicals, equipment, and supplies solutions.
Healx
Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.
InSphero
InSphero is a supplier of organotypic, biological, in vitro 3D microtissues for highly predictive drug testing.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
New Horizon Health
New Horizon Health investment in Debt Financing - ProteoMediX
Walter Fischl
Walter Fischl investment in Venture Round - ProteoMediX
several private
several private investment in Venture Round - ProteoMediX
Zürcher Kantonal Bank
Zürcher Kantonal Bank investment in Venture Round - ProteoMediX
Altos Venture
Altos Venture investment in Venture Round - ProteoMediX
Altos Ventures
Altos Ventures investment in Series C - ProteoMediX
Zürcher Kantonal Bank
Zürcher Kantonal Bank investment in Series C - ProteoMediX
Altos Venture
Altos Venture investment in Series B - ProteoMediX
Zürcher Kantonal Bank
Zürcher Kantonal Bank investment in Series B - ProteoMediX
Zürcher Kantonal Bank
Zürcher Kantonal Bank investment in Series A - ProteoMediX
Key Employee Changes
| Date | New article |
|---|---|
| 2020-01-10 | Proteomedix appoints new CEO to launch their diagnostic test |
Official Site Inspections
http://www.proteomedix.com
- Host name: 159.100.255.20
- IP address: 159.100.255.20
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "ProteoMediX"
Next level diagnostics - ProteoMediX AG
Proteomedix was founded in 2010 as a spin-off company of ETH Zurich to bring together the exceptional and specific expertise of a multi-disciplinary group of the world’s leading scientists …See details»
Proteomedix - Crunchbase Company Profile & Funding
Furthermore, ProteoMediX's diagnostic platform has reached a milestone in expanding diagnostic capabilities worldwide, which implies a broadening of its operational reach and influence in the market. Additionally, the company's …See details»
Proteomedix AG – Swiss Biotech
Proteomedix is a healthcare company whose mission is to transform prostate cancer diagnosis. The lead product Proclarix® is a blood based prostate cancer test panel and risk score …See details»
ProteoMediX
How Proclarix clears the grey zone. Patients with a PSA level between 2 and 10 ng/ml are in a diagnostic grey zone. In these cases, the doctor faces an inconclusive situation without having sufficient information to decide whether …See details»
Blue Water Biotech Acquires Proteomedix as Part of …
Dec 18, 2023 Transaction strengthens commercial business with addition of diagnostics product and initial focus on prostate cancer. CINCINNATI, Dec. 18, 2023 (GLOBE NEWSWIRE) -- …See details»
Proteomedix AG - Venturelab
Proteomedix is a healthcare company whose mission is to transform prostate cancer diagnosis. The company has identified novel biomarker signatures with utility in prostate cancer …See details»
ProteoMediX - VentureRadar
ProteoMediX AG Switzerland Privately Held ProteoMediX AG is a diagnostic company developing non- invasive diagnostic tests for the accurate detection, prognosis and therapy-selection of …See details»
Proteomedix - PharmiWeb.com
Proteomedix was founded in 2010 to bring together the exceptional and specific expertise of a multi-disciplinary group of the world’s leading scientists and clinicians. As a medical need …See details»
Proteomedix - Ownership and Business Overview - Mergr
Dec 18, 2023 Proteomedix is a healthcare company whose mission is to transform prostate cancer diagnosis. The company has identified novel biomarker signatures with utility in …See details»
ProteoMediX AG - VentureRadar
ProteoMediX AG is a diagnostic company developing non- invasive diagnostic tests for the accurate detection, prognosis and therapy-selection of cancer. The company is a spinoff …See details»
Proteomedix Company Profile: Funding, Investors & Partnerships
Proteomedix was founded in 2010 as a spin-off company of ETH Zurich to bring together the exceptional and specific expertise of a multi-disciplinary group of the world’s leading scientists …See details»
ProteoMediX - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money ... Access exclusive financial data. Unlock for free . Sep …See details»
ProteoMediX Company Profile 2024: Valuation, Investors
ProteoMediX General Information Description. Developer of diagnostic biomarkers designed to assist in early detection and define the cancer stage. The company's biomarkers offer …See details»
Proteomedix appoints Helge Lubenow as new CEO
Proteomedix AG Wagistrasse 21 8952 Schlieren Switzerland Tel. +41 44 733 40 90 [email protected] About Proteomedix Proteomedix is a healthcare company whose …See details»
Proteomedix AG - startup.ch
Proteomedix is a healthcare company whose mission is to transform prostate cancer diagnosis. The company has identified novel biomarker signatures with utility in prostate cancer …See details»
Swiss diagnostics company Proteomedix has officially joined …
Dec 18, 2023 Swiss company Proteomedix, focused on improving prostate cancer care and stemming from ETH, has been acquired by US-based Blue Water Biotech on NASDAQ. This …See details»
Proteomedix - Contacts, Employees, Board Members, Advisors
Organization. Proteomedix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News ... Employee Profiles 3. Number of Board Member and Advisor Profiles 5. …See details»
Contact - ProteoMediX AG
Proteomedix. Address. Wagistrasse 23 8952 Schlieren Switzerland Investor and Media Contact Information: Russo Partners, LLC Nic Johnson and Harrison Seidner, PhD Telephone: (212) …See details»
ProteoMediX (Switzerland) Funding: $21.3M - Medical Startups
Dec 10, 2024 ProteoMediX is specialized in the identification of novel biomarkers for the early detection of cancer. The first product currently developed is a blood-based test that enables …See details»
Immunovia launches a strategic partnership with Proteomedix to …
Oct 17, 2022 With this partnership, Immunovia will gain a more flexible R&D organization, increase its R&D productivity, and will focus internal resources on the commercial build up, …See details»